Japanese gynecological benign tumor market is thriving with cutting-edge diagnostic technologies and minimally invasive ...

Scientists that discovered a life-saving drug to treat cancer patients with a faulty gene are marking a special anniversary, and looking back at the impact their work has had around the world.

A drug used against cancer could also be effective against severe coronavirus infection.

Established in 1992 amid the HIV epidemic, the accelerated approval program enables the US Food and Drug Administration (FDA) to grant an initial marketing authorization if a drug shows improvement in ...

The primary objective of the present study was to assess the anti-tumor activity of a combination of trastuzumab with carboplatin and paclitaxel in patients with recurrent or refractory ovarian ...

Recent FDA approvals have included Rubraca (rucaparib), which was approved in 2020 for patients with metastatic castration-resistant prostate cancer that expresses a BRCA mutation, and Lynparza ...